Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
544,377
-
Share change
-
+93,986
-
Total reported value
-
$83,775,755
-
Put/Call ratio
-
34%
-
Price per share
-
$153.87
-
Number of holders
-
89
-
Value change
-
+$14,643,808
-
Number of buys
-
39
-
Number of sells
-
34
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2020
As of 30 Jun 2020,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
544,377 shares.
The largest 10 holders included
ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, MORGAN STANLEY, BROWN ADVISORY INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RAYMOND JAMES & ASSOCIATES, BANK OF AMERICA CORP /DE/, MURPHY CAPITAL MANAGEMENT INC, LPL Financial LLC, and Steward Partners Investment Advisory, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.